Hesperadin (hydrochloride)
Hesperadin hydrochloride is an ATP competitive indolinone inhibitor of Aurora A and B. Hesperadin hydrochloride inhibits Aurora B with an IC50 of 250 nM[1].
Product Specifications
UNSPSC
12352005
Target
Aurora Kinase; Autophagy; Influenza Virus; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hesperadin-hydrochloride.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=CC=C(C=C2/C1=C(NC3=CC=C(C=C3)CN4CCCCC4)\C5=CC=CC=C5)NS(CC)(=O)=O.[H]Cl
Molecular Formula
C29H33ClN4O3S
Molecular Weight
553.12
References & Citations
[1]Neal J, et, al. The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms. Mol Microbiol. 2009 Apr; 72 (2) : 442-58.|[2]Wahafu A, et, al. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide. Pathol Res Pract. 2019 Nov; 215 (11) : 152617.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora B
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9020376-01 0.02 mg (Yeast)
Recombinant Canine parvovirus type 2 Capsid protein VP2, partial
Sign In for Pricing
View Details MBS9020376-02 0.1 mg (Yeast)
Recombinant Canine parvovirus type 2 Capsid protein VP2, partial
Sign In for Pricing
View Details MBS9020376-03 1 mg (Yeast)
Recombinant Canine parvovirus type 2 Capsid protein VP2, partial
Sign In for Pricing
View Details MBS9020376-04 5x 1 mg (Yeast)
Recombinant Canine parvovirus type 2 Capsid protein VP2, partial
Sign In for Pricing
View Details